Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
908.67
818.65
914.11
860.23
801.09
796.82
1,050.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
908.67
818.65
914.11
860.23
801.09
796.82
1,050.16
Raw Material Cost
113.70
107.03
127.23
152.26
127.47
75.90
75.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.61
0.00
0.00
0.00
0.00
86.99
71.96
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.58
6.21
2.81
0.91
1.49
0.46
0.03
Selling and Distribution Expenses
564.23
545.65
575.67
512.91
467.23
524.62
668.58
Other Expenses
-21.40
4.23
8.08
7.49
9.07
-0.08
2.82
Total Expenditure (Excl Depreciation)
726.18
701.24
786.49
740.99
686.91
687.16
844.59
Operating Profit (PBDIT) excl Other Income
182.5
117.4
127.6
119.2
114.2
109.7
205.6
Other Income
26.45
34.02
38.91
42.13
37.16
97.44
107.43
Operating Profit (PBDIT)
242.18
188.29
210.56
200.60
187.81
237.49
347.67
Interest
7.58
6.21
2.81
0.91
1.49
0.46
0.03
Exceptional Items
-6.30
-105.97
-32.46
-10.63
41.68
1.36
-13.90
Gross Profit (PBDT)
794.97
711.62
786.88
707.96
673.62
720.93
974.32
Depreciation
36.48
36.98
43.77
39.27
36.23
30.04
34.66
Profit Before Tax
191.82
39.12
131.52
149.79
191.76
208.36
299.08
Tax
20.26
17.33
-64.84
16.42
21.42
24.67
33.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
165.97
42.22
150.45
101.49
147.99
183.36
266.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
165.97
42.22
150.45
101.49
147.99
183.36
266.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.46
-20.69
37.12
22.40
19.46
-0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
169.42
21.53
187.57
123.89
167.44
183.35
266.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,211.28
3,144.41
3,059.94
2,925.91
2,888.76
3,078.34
2,728.00
Earnings per share (EPS)
1.04
0.27
0.96
0.65
0.94
1.15
1.66
Diluted Earnings per share
1.04
0.27
0.96
0.65
0.94
1.15
1.66
Operating Profit Margin (Excl OI)
19.73%
14.33%
13.99%
13.86%
14.28%
13.81%
19.58%
Gross Profit Margin
25.12%
9.3%
19.18%
21.98%
28.46%
29.92%
31.78%
PAT Margin
18.26%
5.16%
16.46%
11.8%
18.47%
23.01%
25.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 10.99% vs -10.44% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 687.91% vs -88.54% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 39.79% vs -10.13% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 22.58% vs 121.43% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Beijing Konruns Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
908.67
0
908.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
908.67
0
908.67
Raw Material Cost
113.70
0
113.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
254.61
0
254.61
Power Cost
0
0
0.00
Manufacturing Expenses
7.58
0
7.58
Selling and Distribution Expenses
564.23
0
564.23
Other Expenses
-21.40
0.00
-21.40
Total Expenditure (Excl Depreciation)
726.18
0
726.18
Operating Profit (PBDIT) excl Other Income
182.49
0.00
182.49
Other Income
26.45
0
26.45
Operating Profit (PBDIT)
242.18
0
242.18
Interest
7.58
0
7.58
Exceptional Items
-6.30
0
-6.30
Gross Profit (PBDT)
794.97
0
794.97
Depreciation
36.48
0
36.48
Profit Before Tax
191.82
0
191.82
Tax
20.26
0
20.26
Provisions and contingencies
0
0
0.00
Profit After Tax
165.97
0
165.97
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
165.97
0
165.97
Share in Profit of Associates
0
0
0.00
Minority Interest
3.46
0
3.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
169.42
0
169.42
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,211.28
0
3,211.28
Earnings per share (EPS)
1.04
0
1.04
Diluted Earnings per share
1.04
0
1.04
Operating Profit Margin (Excl OI)
19.73%
0%
0.00
19.73%
Gross Profit Margin
25.12%
0%
0.00
25.12%
PAT Margin
18.26%
0%
0.00
18.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 90.87 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.99% vs -10.44% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 16.94 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 687.91% vs -88.54% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.57 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 39.79% vs -10.13% in Dec 2024
Annual - Interest
Interest 0.76 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 22.58% vs 121.43% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.73%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
